ScholarIQanswers from OpenAlex & ORCID
Deborah Farr
ResearcherPublications, citations & collaboration network
Deborah Farr is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Deborah Farr have?
ScholarIQindexed works
Deborah Farr has 78 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Deborah Farr have?
ScholarIQcitation count
Deborah Farr has 757 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Deborah Farr?
ScholarIQh-index
Deborah Farr has an h-index of 14 in OpenAlex.
What is the i10-index of Deborah Farr?
ScholarIQi10-index
Deborah Farr has an i10-index of 19 in OpenAlex.
What is the ORCID of Deborah Farr?
ScholarIQorcid
The ORCID for Deborah Farr is on the source record.
What is the OpenAlex record for Deborah Farr?
ScholarIQopenalex
The OpenAlex for Deborah Farr is on the source record.
What are the most-cited papers on Deborah Farr?
ScholarIQmost cited works
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement
David Al‐Adra, Laura L. Hammel, John P. Roberts, E. Steve Woodle, Deborah J. Levine, Didier A. Mandelbrot, Elizabeth C. Verna, Jayme E. Locke, Jonathan D’Cunha, Maryjane Farr, Deirdre Sawinski, Piyush K. Agarwal, Jennifer K. Plichta, Sandhya Pruthi, Deborah Farr, Richard D. Carvajal, John Walker, Fiona O. Zwald, Thomas M. Habermann, Morie A. Gertz, Philip J. Bierman, Don S. Dizon, Carrie Langstraat, Talal Al‐Qaoud, Scott E. Eggener, John Richgels, George J. Chang, Cristina B. Geltzeiler, Gonzalo Sapisochín, Rocco Ricciardi, Alexander S. Krupnick, Cassie C. Kennedy, Nisha Mohindra, David P. Foley, Kymberly D. Watt
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement
David Al‐Adra, Laura L. Hammel, John P. Roberts, E. Steve Woodle, Deborah J. Levine, Didier A. Mandelbrot, Elizabeth C. Verna, Jayme E. Locke, Jonathan D’Cunha, Maryjane Farr, Deirdre Sawinski, Piyush K. Agarwal, Jennifer K. Plichta, Sandhya Pruthi, Deborah Farr, Richard D. Carvajal, John Walker, Fiona O. Zwald, Thomas M. Habermann, Morie A. Gertz, Philip J. Bierman, Don S. Dizon, Carrie Langstraat, Talal Al‐Qaoud, Scott Eggener, John Richgels, George J. Chang, Cristina B. Geltzeiler, Gonzalo Sapisochín, Rocco Ricciardi, Alexander S. Krupnick, Cassie C. Kennedy, Nisha Mohindra, David P. Foley, Kymberly D. Watt
Safety and Feasibility of Single-Port Robotic-Assisted Nipple-Sparing Mastectomy
Deborah Farr, Nicholas T. Haddock, Juan Tellez, Imad Radi, Rodrigo E. Alterio, Brendan Sayers, Herbert J. Zeh
Disparities in the Operative Experience Between Female and Male General Surgery Residents
Leah K. Winer, Sarah Kader, Jonathan S. Abelson, Austin C. Hammaker, Chukwuma N. Eruchalu, James C. Etheridge, Nancy L. Cho, Darci C. Foote, Felicia A. Ivascu, Savannah Smith, Lauren M. Postlewait, Kathriena Greenwell, Katherine M. Meister, Kelsey B. Montgomery, Polina Zmijewski, Samuel E. Byrd, Mary K. Kimbrough, Stephen Stopenski, Jeffry Nahmias, Jalen Harvey, Deborah Farr, Zachary M. Callahan, Joshua A. Marks, Christopher C. Stahl, Motaz Al Yafi, Jeffrey M. Sutton, Ali Elsaadi, Samuel J. Campbell, Shah-Jahan M. Dodwad, Sasha D. Adams, Matthew R. Woeste, Robert C.G. Martin, Purvi Patel, Michael J. Anstadt, Bilal Waqar Nasim, Ross E. Willis, Jitesh A. Patel, Melisa R. Newcomb, Brian C. George, Ralph C. Quillin, Alexander R. Cortez
Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients
Jean Shiao, K. Thomas, Asal Rahimi, Roshni Rao, Jingsheng Yan, Xian‐Jin Xie, Marcelo Dasilva, Ann Spangler, M. Leitch, Rachel Wooldridge, Aeisha Rivers, Deborah Farr, Barbara Haley, D. W. Nathan Kim